MOBILion Systems, Inc. has established a Proteomics Advisory Board consisting of seven leading experts in the field to provide guidance on their efforts to advance complex sample analysis technology in proteomics. The company aims to revolutionize mass spectrometry by improving precision analysis, targeting low-abundance signals, and identifying complex biomolecules more effectively. Daniel DeBord, Ph.D., CTO of MOBILion Systems, expressed gratitude for the opportunity to collaborate with these visionary leaders who have made significant contributions to the proteomics landscape. He highlighted the company’s innovative PAMAF operating mode, which sets a new standard for speed and sensitivity in complex sample analysis. The expertise of the advisory board will play a crucial role in developing products that capitalize on this technology to address the key challenges faced by researchers in the field. MOBILion Systems is committed to pushing the boundaries of what is achievable in proteomics research and innovation. For more information, contact Healthcare Edge Editor at Editor@Executives-edge.com.
Source
Photo credit finance.yahoo.com